“syphilis”的搜索结果，显示 631-640 项，共有 9818 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla. The purpose of this study is to evaluate the effects of ibrutinib and rituximab with or without venetoclax in treating ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The aim of this study is to create a patient and patient-advocate catalyzed tumor bank for the retrieval, processing, analysis, and maintenance of ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and ...

5. 心血管医学- 临床试验- 妙佑医疗国际

   Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) or cardiac ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Rochester, Minn. The purpose of this study is to evaluate the effects of ibrutinib and rituximab with or without venetoclax in treating ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...